CellTrend GmbH
Germany DE-MF-000030872 Last updated 21 Oct 2026
Is this your brand? Sign in to claim this brand
- Devices
- 6
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
Anti-mAChR4 AB Ref 15400
Anti-Beta1AR AB Ref 12600
anti-AT1R AB Ref 12000
Anti-Beta2AR AB Ref 12700
Anti-ETAR AB Ref 12100
Anti-mAChR3 AB Ref 15300
About
CellTrend GmbH was founded in 1998 and currently employs 10 people. The biotechnology company works as a contract research institute (CRO) on behalf of the pharmaceutical industry. Cell-based bio-assays are carried out for drug discovery and toxicology studies. The second focus is on immunoassays. New biomarkers are established and ELISAs are developed, produced and distributed.
What CellTrend GmbH makes
CellTrend GmbH develops and provides immunoassays, including monoclonal antibodies (Anti-mAChR4, Anti-Beta1AR, Anti-AT1R, Anti-Beta2AR, Anti-ETAR, Anti-mAChR3) for research applications. These assays support biomarker discovery and drug development by enabling precise detection of receptor-specific targets in biological samples.
The company’s immunoassays fall under In Vitro Diagnostic (IVD) General classification and are registered in the EUDAMED database. The portfolio is designed for research use in drug discovery and toxicology, adhering to regulatory requirements for in vitro diagnostics within the European Union.
Frequently asked questions
What types of medical devices does CellTrend GmbH develop and provide?
CellTrend GmbH specializes in developing and providing immunoassays, specifically monoclonal antibodies such as Anti-mAChR4, Anti-Beta1AR, Anti-AT1R, Anti-Beta2AR, Anti-ETAR, and Anti-mAChR3. These assays are designed for research applications, enabling precise detection of receptor-specific targets in biological samples. They support biomarker discovery and drug development by facilitating studies in drug discovery and toxicology.
Where is CellTrend GmbH based, and what regulatory database lists its devices?
CellTrend GmbH is based in Germany. Its immunoassays are listed in the EUDAMED database, which is the European Union’s central registry for medical devices. This registration is required for in vitro diagnostics (IVDs) to ensure transparency and compliance with EU regulatory requirements.
How are the devices developed by CellTrend GmbH classified under medical device regulations?
The immunoassays developed by CellTrend GmbH fall under the In Vitro Diagnostic (IVD) General classification. This classification applies because these assays are intended for in vitro diagnostic use, such as detecting biomarkers or receptor targets in biological samples for research purposes. The classification determines the regulatory pathway and compliance requirements they must meet.
Are CellTrend GmbH’s devices primarily used for clinical diagnostics or research purposes?
CellTrend GmbH’s immunoassays are designed exclusively for research applications, including drug discovery and toxicology studies. While they may share similarities with clinical diagnostics, they are not intended for direct patient diagnosis or treatment decisions. Their purpose is to support scientific research and preclinical development in pharmaceutical and biotechnology fields.
Information
- Country
- Germany
- Address
- 3, Im Biotechnologiepark, Luckenwalde, Germany
- Website
- www.celltrend.de
- [email protected]
- Phone
- +49 3371 6199600
- PRRC contact
- Kai Schulze-Forster
- EUDAMED SRN
- DE-MF-000030872